Update on the role of palliative oxygen

Publication Type:
Journal Article
Current Opinion in Supportive and Palliative Care, 2011, 5 (2), pp. 87 - 91
Issue Date:
Filename Description Size
Thumbnail2011001125OK.pdf392.58 kB
Adobe PDF
Full metadata record
On the basis of the findings of this review, the routine use of palliative oxygen therapy without detailed assessment of pathogenesis and reversibility of symptoms cannot be justified. Promoting self-management strategies, such as cool airflow across the face, exercise and psychological support for patients and carers, should be considered before defaulting to oxygen therapy. If palliative oxygen therapy is considered for individuals with transient or mild hypoxaemia, a therapeutic trial should be conducted with clinical review after 3 days to assess the net clinical benefit and patient preference. © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.
Please use this identifier to cite or link to this item: